An intraoperative pathology exam demonstrated a high-grade malignant neoplasm with necrosis, and the final pathology was found to be glioblastoma, isocitrate dehydrogenase 1 (IDH-1) (R132H)-wildtype, central nervous system (CNS) WHO Grade IV. Here, IDH1 is linked to glioblastoma.